
Daiken Medical (7775) Interim Earnings: Operating Income Decreased by 23.9% YoY to 214 Million Yen
StockClub
公開日時: Jul 31, 2026, 05:36 PM GMT+9
Sentiment Analysis
Daiken Medical (7775) announced its interim financial results, reporting operating income of 214 million yen, down 23.9% year-on-year. Net sales were 2,439 million yen (down 2.3% year-on-year), ordinary income was 213 million yen (down 24.4% year-on-year), and net income was 167 million yen (down 22.3% year-on-year). Earnings per share (EPS) stood at 5.83 yen.
From a financial perspective, the company maintains a capital adequacy ratio of 68.6% and cash and cash equivalents of 2.78 billion yen. Operating cash flow was positive at 570 million yen, and free cash flow reached 240 million yen, with interest-bearing debt at 2.11 billion yen and retained earnings at 8.53 billion yen.
(Correction, September 20, 2026: interest-bearing debt was restated as the total of borrowings, bonds and related items in the original disclosure, 2027年3月期第1四半期決算短信〔日本基準〕(非連結).)
個別の投資に関する推奨やアドバイスを提供することを意図しておりません。ここで述べられている意見や見解は、あくまでも各記事の個人的見解です。